In this aerial photo, sediment and mixed river water is seen as a tanker ship moves upriver in Plaquemines Parish, La., Tuesday, Sept. 26, 2023. A salt water wedge slowly moving upriver from the Gulf of Mexico, due to the unusually low water level in the river, may threaten municipal water supplies, potentially even New Orleans. (AP Photo/Gerald Herbert)
By Sara Cline
President Joe Biden announced Wednesday that federal disaster assistance is available for Louisiana, which is working to slow a mass inflow of salt water creeping up the Mississippi River and threatening drinking water supplies in the southern part of the state.
Biden's action authorizes the Department of Homeland Security and the Federal Emergency Management Agency to coordinate all disaster relief efforts, according to a news release from the White House. Additionally, the declaration will allow for more equipment, resources and federal money to address the saltwater intrusion.
“I’m grateful to the Biden administration for making this request a priority and responding quickly to help the people of South Louisiana,” Louisiana Gov. John Bel Edwards said in a news release Wednesday.
For the second year in a row, salt water from the Gulf of Mexico has moved further up the Mississippi, threatening drinking water in communities that rely on the river for fresh water. Typically, the river’s mighty flow keeps mass amounts of salt water from reaching too far inland, but hot and dry conditions across the country this summer triggered drought that slowed the Mississippi’s flow and lowered its water levels.
In parts of Plaquemines Parish, the southeast corner of Louisiana encompasses the final stretch of the Mississippi River before it reaches the Gulf of Mexico, residents have relied on bottled water for cooking and drinking since June.
Drinking water advisories have been issued for some communities in the parish, warning people the water is unsafe to drink, especially for people with kidney disease, high blood pressure, those on a low-sodium diet, infants and pregnant women.
Now the salt water is moving further upriver and will likely reach Orleans, St. Bernard and Jefferson parishes by mid-to-late October, officials say.
Edwards wrote to Biden earlier this week to ask for federal help. In his letter, Edwards said that the issue “is of such severity and magnitude” that state and local authorities can no longer manage it on their own. Federal assistance is “necessary to save lives and to protect property, public health and safety or to lessen or avert the threat of a disaster,” the governor wrote.
While officials say they are praying for rain to help increase the velocity of the drought-stricken river they are also taking matters into their own hands — raising the height of an underwater levee used to block or slow the salt water and bringing in 15 million gallons of fresh water to treatment facilities in impacted areas.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
